Optimal therapy for adolescents and young adults with acute lymphoblastic leukemia-current perspectives

Adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have worse prognosis than children. Differing biology of ALL may account for some of this disparity in outcome, with AYA patients having far lower incidence of good risk cytogenetic abnormalities, and higher proportion of pat...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Jae Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386896/
https://www.ncbi.nlm.nih.gov/pubmed/32719173
http://dx.doi.org/10.5045/br.2020.S005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386896/
https://www.ncbi.nlm.nih.gov/pubmed/32719173
http://dx.doi.org/10.5045/br.2020.S005

Ejemplares similares